CVS Unit To Pay $5.25M To Settle False Data Allegations
On Monday, the Department of Justice announced that it reached a $5.25 million settlement with CVS Caremark subsidiary RxAmerica to resolve allegations that the company submitted false generic prescription drug pricing data to Medicare between 2007 and 2008. DOJ officials said that in many cases, the actual costs for the drugs were higher than those that RxAmerica submitted.
- "CVS To Pay $5 Million To Settle Drug Pricing Allegations" (AP/Modern Healthcare, 10/15).